These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15959557)

  • 1. Causes and consequences of DNA hypomethylation in human cancer.
    Hoffmann MJ; Schulz WA
    Biochem Cell Biol; 2005 Jun; 83(3):296-321. PubMed ID: 15959557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation in cancer: too much, but also too little.
    Ehrlich M
    Oncogene; 2002 Aug; 21(35):5400-13. PubMed ID: 12154403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.
    Esteller M; Herman JG
    J Pathol; 2002 Jan; 196(1):1-7. PubMed ID: 11748635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Global DNA hipomethylation--the meaning in carcinogenesis].
    Guz J; Foksiński M; Oliński R
    Postepy Biochem; 2010; 56(1):16-21. PubMed ID: 20499677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of DNA methylation and clinicopathological diversity of human cancers.
    Kanai Y
    Pathol Int; 2008 Sep; 58(9):544-58. PubMed ID: 18801069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
    Paluszczak J; Baer-Dubowska W
    Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes.
    Gibbons RJ
    Hum Mol Genet; 2005 Apr; 14 Spec No 1():R85-92. PubMed ID: 15809277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylation of repeated DNA sequences in cancer.
    Ross JP; Rand KN; Molloy PL
    Epigenomics; 2010 Apr; 2(2):245-69. PubMed ID: 22121873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation in urological malignancies (review).
    Schulz WA
    Int J Oncol; 1998 Jul; 13(1):151-67. PubMed ID: 9625817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
    Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.
    Cadieux B; Ching TT; VandenBerg SR; Costello JF
    Cancer Res; 2006 Sep; 66(17):8469-76. PubMed ID: 16951158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal regional hypermethylation in cancer cells.
    Baylin SB
    AIDS Res Hum Retroviruses; 1992 May; 8(5):811-20. PubMed ID: 1515232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.
    Tost J
    Methods Mol Biol; 2009; 507():3-20. PubMed ID: 18987802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers.
    Rodriguez J; Frigola J; Vendrell E; Risques RA; Fraga MF; Morales C; Moreno V; Esteller M; Capellà G; Ribas M; Peinado MA
    Cancer Res; 2006 Sep; 66(17):8462-9468. PubMed ID: 16951157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The necessity of a human epigenome project.
    Esteller M
    Carcinogenesis; 2006 Jun; 27(6):1121-5. PubMed ID: 16699174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genome methylation and its role in functioning of the eukaryotic organism].
    Prokhorchuk AV; Ruzov AS
    Genetika; 2000 Nov; 36(11):1475-86. PubMed ID: 11094764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
    Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.